지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.3
- 수록면
- 21 - 25 (5page)
이용수
초록· 키워드
오류제보하기
Purpose: Burning mouth syndrome (BMS) is a chronic pain condition involving the oral and perioral regions, often characterized by a burning sensation and pain in elderly patients. In this study, we investigated the effectiveness of pharmacological agents for the treatment of BMS patients through a retrospective chart review.
Methods: We enrolled 61 BMS subjects (57 females, 4 males; 66.4±10.9 years of age) from among consecutive patients treated pharmacologically from January 2014 to June 2015 at Chonnam National University Dental Hospital. Patients with secondary BMS associated with local factors were excluded. The treatment period, number of pharmacological agents tried, and effectiveness of the drugs administered to each subject were analyzed.
Results: The mean treatment period for the management of BMS was 2.5 months. More than three agents were tried to control BMS symptoms in 17 subjects (27.9%); two agents were used in 10 subjects (16.4%), and a single agent in 24 subjects (39.3%). Clonazepam was prescribed most frequently and was effective at relieving symptoms in 30 of 39 subjects (76.9%). Paroxetine was moderately effective, relieving symptoms in 7 of 17 subjects (41.2%). Some of the subjects benefited from tricyclic antidepressants, gabapentin, and lipoic acid. A topical local anesthetic used to supplement other systemic agents had ameliorating effects in four of six subjects.
Conclusions: Within the study limitations, clonazepam was the most effective drug and antidepressants were efficacious in some subjects for relieving the symptoms of BMS. These pharmacological agents could be considered as first-line drugs for the management of BMS.
Methods: We enrolled 61 BMS subjects (57 females, 4 males; 66.4±10.9 years of age) from among consecutive patients treated pharmacologically from January 2014 to June 2015 at Chonnam National University Dental Hospital. Patients with secondary BMS associated with local factors were excluded. The treatment period, number of pharmacological agents tried, and effectiveness of the drugs administered to each subject were analyzed.
Results: The mean treatment period for the management of BMS was 2.5 months. More than three agents were tried to control BMS symptoms in 17 subjects (27.9%); two agents were used in 10 subjects (16.4%), and a single agent in 24 subjects (39.3%). Clonazepam was prescribed most frequently and was effective at relieving symptoms in 30 of 39 subjects (76.9%). Paroxetine was moderately effective, relieving symptoms in 7 of 17 subjects (41.2%). Some of the subjects benefited from tricyclic antidepressants, gabapentin, and lipoic acid. A topical local anesthetic used to supplement other systemic agents had ameliorating effects in four of six subjects.
Conclusions: Within the study limitations, clonazepam was the most effective drug and antidepressants were efficacious in some subjects for relieving the symptoms of BMS. These pharmacological agents could be considered as first-line drugs for the management of BMS.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (32)
참고문헌 신청
Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999;28:350-354.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160.
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
Clark G, Dionne R. Orofacial pain: a guide to medications and management. Chichester: John Wiley & Sons; 2012. pp. 240-243.
Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006;12: 152-155.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160.
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
Clark G, Dionne R. Orofacial pain: a guide to medications and management. Chichester: John Wiley & Sons; 2012. pp. 240-243.
Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006;12: 152-155.
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Treatment for Burning Mouth Syndrome: A Clinical Review
Journal of Oral Medicine and Pain
2023 .03
-
구강작열감 증후군
대한치과의사협회지
2017 .09
-
Potential Biomarkers for an Evidence-Based Diagnosis of Burning Mouth Syndrome
Journal of Oral Medicine and Pain
2023 .12
-
Sleep Quality Evaluation Using Self-Reported Questionnaires in Patients with Burning Mouth Syndrome
Journal of Oral Medicine and Pain
2016 .12
-
Clinical manifestations and management of burning mouth syndrome
Oral Biology Research
2016 .01
-
A Critical View on New and Future Antidepressants
Clinical Psychopharmacology and Neuroscience
2024 .05
-
Psychological Aspects of Burning Mouth Syndrome
Journal of Oral Medicine and Pain
2015 .03
-
구강작열감 증후군에 대한 논문 고찰
구강회복응용과학지
2019 .09
-
항우울제로 새롭게 등장한 ‘남용 물질’ - 약리학적 기전, 항우울 효과, 오남용 가능성에 대한 고찰
신경정신의학
2022 .11
-
Effects of Pregabalin in Primary Burning Mouth Syndrome Patients Unresponsive to Topical Clonazepam Treatment : A Retrospective Pilot Study
Journal of Oral Medicine and Pain
2016 .03
-
小柴胡湯 위주의 한방 치료로 호전된 구강 작열감 증후군 환자 3명에 대한 증례 보고
한방안이비인후피부과학회지
2021 .11
-
한방 치료로 호전된 구강 작열감 증후군 환자 6명에 대한 증례보고
한방안이비인후피부과학회지
2019 .01
-
Burning measure for burning mouth syndrome: a systematic review
대한구강악안면외과학회지
2024 .04
-
항우울제 중단 증후군
신경정신의학
2024 .05
-
The efficiency of topical anesthetics as antimicrobial agents: A review of use in dentistry
Journal of dental anesthesia and pain medicine
2018 .01
-
새로운 우울증 치료 약물
생물정신의학
2016 .01
-
구강 작열감 증후군에서 국소 항진균제의 치료 효과
대한이비인후-두경부외과학회지
2019 .01
-
Antidiuretic Hormone Levels in Men with Burning Mouth Syndrome : A Pilot Study
Journal of Oral Medicine and Pain
2017 .12
-
Antidepressants in Spine Surgery: A Systematic Review to Determine Benefits and Risks
Asian Spine Journal
2019 .01
-
우울증과 항우울작용에 관한 p11(S100A10)의 역할
생물정신의학
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2016-515-002647726